• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Immunis Licenses Treatment Candidate For Dyskinesia Associated

    BUSINESSWIRE

    Zydus Launches India`s First Flu Vaccine For 2025 South Strain

    EXPRESSPHARMA

    Immunis Starts Preclinical Studies on Canine Muscle Atrophy

    BUSINESSWIRE

    Immunis And Springbok Partner To Assess IMMUNA For Sarcopenia

    BUSINESSWIRE

    Immunis Appoints Dr. Christina Weng to its Advisory Board

    BUSINESSWIRE

    Immunis Partners with Japanese Drug Company Toray to Reverse Sarcopenia

    BUSINESSWIRE

    Immunis Discusses with Experts Why the Immune System is the Key to Healthspan

    BUSINESSWIRE

    Immunis Publishes Research Showing Secretomes Improve Metabolism &

    BUSINESSWIRE

    Immunis Chairman Dr. Hans Keirstead to Present Abundance360 Moonshot

    BUSINESSWIRE

    Immunis Chairman Dr. Hans Keirstead is an Invited Speaker at Conference

    BUSINESSWIRE

    Immunis Chairman Dr. Hans Keirstead to Speak at the Longevity Investors Lunch

    BUSINESSWIRE

    Immunis Chairman Dr. Hans Keirstead is Honored As One of OCBJ’s OC500

    BUSINESSWIRE

    Immunis Chairman Dr. Hans Keirstead to Present at BIO Europe Conference

    BUSINESSWIRE

    Immunis is a Finalist for Best of America Small Business Awards – Vote for Us!!!

    BUSINESSWIRE

    Immunis CBO Mark Cabato to Deliver Keynote at Drug Discovery Strategic Summit

    BUSINESSWIRE

    Immunis Chairman Dr. Hans Keirstead to Present at Innovative Therapies Days

    BUSINESSWIRE

    Immunis Chairman Dr. Hans Keirstead to Present at Advanced Therapies in Portugal

    BUSINESSWIRE

    Immunis is a Finalist for High Tech Award for “Best Emerging Technology Company”

    BUSINESSWIRE

    Immunis Chairman Dr. Hans Keirstead to Speak at Ending Age-Related Diseases Summit

    BUSINESSWIRE

    Immunis’ Phase 1/2a Approved by Data Safety and Monitoring Board to Proceed with Dose Escalation

    BUSINESSWIRE

    Immunis Nominated for Prix Galien Award for “Best Startup”

    BUSINESSWIRE

    Immunis Releases Article Highlighting the Potential of Cell Secretome Therapies

    BUSINESSWIRE

    Immunis Appoints Neil Sahota as Chief Artificial Intelligence Officer

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.